Knight Therapeutics Stock Probability of Future Stock Price Finishing Under 3.10
| GUD Stock | CAD 5.29 0.01 0.19% |
Knight |
Knight Therapeutics Target Price Odds to finish below 3.10
The tendency of Knight Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to C$ 3.10 or more in 90 days |
| 5.29 | 90 days | 3.10 | near 1 |
Based on a normal probability distribution, the odds of Knight Therapeutics to drop to C$ 3.10 or more in 90 days from now is near 1 (This Knight Therapeutics probability density function shows the probability of Knight Stock to fall within a particular range of prices over 90 days) . Probability of Knight Therapeutics price to stay between C$ 3.10 and its current price of C$5.29 at the end of the 90-day period is about 7.95 .
Assuming the 90 days trading horizon Knight Therapeutics has a beta of 0.14. This usually indicates as returns on the market go up, Knight Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Knight Therapeutics will be expected to be much smaller as well. Additionally Knight Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Knight Therapeutics Price Density |
| Price |
Predictive Modules for Knight Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Knight Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Knight Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Knight Therapeutics is not an exception. The market had few large corrections towards the Knight Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Knight Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Knight Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.12 | |
β | Beta against Dow Jones | 0.14 | |
σ | Overall volatility | 0.27 | |
Ir | Information ratio | -0.1 |
Knight Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Knight Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Knight Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Knight Therapeutics generated a negative expected return over the last 90 days | |
| The company reported the revenue of 328.2 M. Net Loss for the year was (16.84 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Latest headline from news.google.com: Knight Therapeutics investors are sitting on a loss of 33 percent if they invested five years ago - Yahoo Finance |
Knight Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Knight Stock often depends not only on the future outlook of the current and potential Knight Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Knight Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 107.5 M | |
| Cash And Short Term Investments | 154.4 M |
Knight Therapeutics Technical Analysis
Knight Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Knight Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Knight Therapeutics. In general, you should focus on analyzing Knight Stock price patterns and their correlations with different microeconomic environments and drivers.
Knight Therapeutics Predictive Forecast Models
Knight Therapeutics' time-series forecasting models is one of many Knight Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Knight Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Knight Therapeutics
Checking the ongoing alerts about Knight Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Knight Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Knight Therapeutics generated a negative expected return over the last 90 days | |
| The company reported the revenue of 328.2 M. Net Loss for the year was (16.84 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Latest headline from news.google.com: Knight Therapeutics investors are sitting on a loss of 33 percent if they invested five years ago - Yahoo Finance |
Other Information on Investing in Knight Stock
Knight Therapeutics financial ratios help investors to determine whether Knight Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Knight with respect to the benefits of owning Knight Therapeutics security.